[go: up one dir, main page]

RU2016121001A3 - - Google Patents

Download PDF

Info

Publication number
RU2016121001A3
RU2016121001A3 RU2016121001A RU2016121001A RU2016121001A3 RU 2016121001 A3 RU2016121001 A3 RU 2016121001A3 RU 2016121001 A RU2016121001 A RU 2016121001A RU 2016121001 A RU2016121001 A RU 2016121001A RU 2016121001 A3 RU2016121001 A3 RU 2016121001A3
Authority
RU
Russia
Application number
RU2016121001A
Other languages
Russian (ru)
Other versions
RU2016121001A (ru
RU2676101C2 (ru
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of RU2016121001A publication Critical patent/RU2016121001A/ru
Publication of RU2016121001A3 publication Critical patent/RU2016121001A3/ru
Application granted granted Critical
Publication of RU2676101C2 publication Critical patent/RU2676101C2/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/28Insulins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
RU2016121001A 2014-05-22 2015-05-19 Инсулинсодержащий препарат пролонгированного действия RU2676101C2 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
RU2014120626 2014-05-22
RU2014120626/15A RU2014120626A (ru) 2014-05-22 2014-05-22 Инсулинсодержащий препарат пролонгированного действия
PCT/RU2015/000317 WO2015178806A1 (ru) 2014-05-22 2015-05-19 Инсулинсодержащий препарат пролонгированного действия

Publications (3)

Publication Number Publication Date
RU2016121001A RU2016121001A (ru) 2018-06-22
RU2016121001A3 true RU2016121001A3 (de) 2018-06-22
RU2676101C2 RU2676101C2 (ru) 2018-12-26

Family

ID=54554358

Family Applications (2)

Application Number Title Priority Date Filing Date
RU2014120626/15A RU2014120626A (ru) 2014-05-22 2014-05-22 Инсулинсодержащий препарат пролонгированного действия
RU2016121001A RU2676101C2 (ru) 2014-05-22 2015-05-19 Инсулинсодержащий препарат пролонгированного действия

Family Applications Before (1)

Application Number Title Priority Date Filing Date
RU2014120626/15A RU2014120626A (ru) 2014-05-22 2014-05-22 Инсулинсодержащий препарат пролонгированного действия

Country Status (6)

Country Link
US (1) US20170136096A1 (de)
EP (1) EP3254688A4 (de)
CN (1) CN106794226A (de)
HK (1) HK1248118A1 (de)
RU (2) RU2014120626A (de)
WO (1) WO2015178806A1 (de)

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4908350A (en) * 1985-10-31 1990-03-13 The Regents Of The University Of California Hyperosmotic/hyperoncotic solutions for resuscitation of hypodynamic shock
JPH01287041A (ja) * 1988-05-13 1989-11-17 Rooman Kogyo:Kk 徐放性製剤
GB2237510B (en) * 1989-11-04 1993-09-15 Danbiosyst Uk Small particle drug compositions for nasal administration
US5416071A (en) * 1991-03-12 1995-05-16 Takeda Chemical Industries, Ltd. Water-soluble composition for sustained-release containing epo and hyaluronic acid
US6284727B1 (en) * 1993-04-07 2001-09-04 Scios, Inc. Prolonged delivery of peptides
US7303768B2 (en) * 1998-07-24 2007-12-04 Seo Hong Yoo Preparation of aqueous clear solution dosage forms with bile acids
SE9904121D0 (sv) * 1999-11-15 1999-11-15 Gustaf Jederstroem Hydrophobe biomolecular structure
EP1296660A4 (de) * 2000-06-27 2005-04-13 Mi Tech Company Ltd Zubereitung zur kontrollierten freisetzung von insulin und deren herstellungsmethode
FR2822834B1 (fr) * 2001-04-02 2005-02-25 Flamel Tech Sa Suspension colloidale de nanoparticules a base de copolymeres amphiphile pour la vectorisation de principes actifs et leur mode de preparation
WO2003053460A1 (en) * 2001-12-19 2003-07-03 Eli Lilly And Company Crystalline compositions for controlling blood glucose
US20040005999A1 (en) * 2002-03-07 2004-01-08 Andreasen Kasper Huus Polyamino acid-based particle insulin preparation
US20030211976A1 (en) * 2002-03-07 2003-11-13 Andreasen Kasper Huus Polyamino acid-based particle insulin formulation
CA2518136A1 (en) * 2003-03-04 2004-09-16 The Technology Development Company Ltd. Oral insulin composition and methods of making and using thereof
AU2005291233B2 (en) * 2004-10-05 2011-02-03 Novo Nordisk A/S A pharmaceutical formulation comprising crystalline insulin and dissolved insulin
US8679540B2 (en) * 2006-06-09 2014-03-25 Flamel Technologies Pharmaceutical formulations for the prolonged release of active principle(s), and their applications, especially therapeutic applications
EP2017288A1 (de) * 2007-07-16 2009-01-21 Novo Nordisk A/S Proteasestabilisierte pegylierte Insulinanaloga
US20110189299A1 (en) * 2008-07-01 2011-08-04 Nitto Denko Corporation Pharmaceutical composition containing surface-coated microparticles
EA013569B1 (ru) * 2009-02-24 2010-06-30 Ооо "Научно-Производственный Комплекс "Наносистема"" Фармацевтическая композиция рифабутина для лечения туберкулеза и заболеваний, опосредованных helicobacter pylori, способ ее получения и способ лечения
US20120094902A1 (en) * 2009-03-27 2012-04-19 Adocia Fast-acting insulin formulation
CN102397535B (zh) * 2010-09-15 2013-08-28 中国科学院生物物理研究所 胰岛素结晶微球、其混悬剂、以及制备方法

Also Published As

Publication number Publication date
EP3254688A4 (de) 2018-03-14
WO2015178806A1 (ru) 2015-11-26
EP3254688A1 (de) 2017-12-13
US20170136096A1 (en) 2017-05-18
RU2016121001A (ru) 2018-06-22
CN106794226A (zh) 2017-05-31
RU2014120626A (ru) 2015-11-27
RU2676101C2 (ru) 2018-12-26
HK1248118A1 (en) 2018-10-12

Similar Documents

Publication Publication Date Title
BR112016020621A2 (de)
BR112016015894A2 (de)
BR112016016490A2 (de)
BR112016017201A2 (de)
BR112016019924A2 (de)
BR112016021214A2 (de)
BR112016020808A2 (de)
BR112016016329A2 (de)
BR112016015494A2 (de)
BR112016020813A2 (de)
BR112016020280A2 (de)
BR112016016310A2 (de)
BR112016013757A2 (de)
AP2017009684A0 (de)
BR112016020810A2 (de)
BR112016020585A2 (de)
BR112016016461A2 (de)
BR112016017236A2 (de)
BR112016015965A2 (de)
BR112016017033A2 (de)
BR112016015625A2 (de)
BR112016016075A2 (de)
BR112016020393A2 (de)
BR112016015557A2 (de)
BR112016021189A2 (de)

Legal Events

Date Code Title Description
PC41 Official registration of the transfer of exclusive right

Effective date: 20190424